Search

Your search keyword '"Genentech Inc. -- Intellectual property"' showing total 353 results

Search Constraints

Start Over You searched for: Descriptor "Genentech Inc. -- Intellectual property" Remove constraint Descriptor: "Genentech Inc. -- Intellectual property" Topic biotechnology industry -- intellectual property Remove constraint Topic: biotechnology industry -- intellectual property
353 results on '"Genentech Inc. -- Intellectual property"'

Search Results

1. Patent Issued for Optimized variants of anti-VEGF antibodies (USPTO 12121586)

2. Researchers Submit Patent Application, 'Stable Anti-Cd79b Immunoconjugate Formulations', for Approval (USPTO 20240325559)

3. Patent Issued for Methods for preparing antibody drug conjugates (USPTO 12090211)

4. High Court refuses interim injunction against Zydus' breast cancer drug

5. 'Composition Comprising Antibody That Binds To Domain Ii Of Her2 And Acidic Variants Thereof' in Patent Application Approval Process (USPTO 20240262932)

6. Patent Application Titled 'Ion Exchange Membrane Chromatography' Published Online (USPTO 20240247027)

7. Patent Issued for Methods and compositions comprising a KRasG12C inhibitor and a VEGF inhibitor for treating solid tumors (USPTO 12016862)

8. Patent Application Titled 'Methods For Treating Spinal Muscular Atrophy' Published Online (USPTO 20240173325)

9. Patent Issued for Ion exchange membrane chromatography (USPTO 11945837)

10. Patent Application Titled 'Composition Comprising Antibody That Binds To Domain Ii Of Her2 And Acidic Variants Thereof' Published Online (USPTO 20230416401)

11. Patent Issued for Production of proteins in glutamine-free cell culture media (USPTO 12103975)

12. Patent Issued for Prevention of disulfide bond reduction during recombinant production of polypeptides (USPTO 12098211)

13. Patent Issued for Anti-hypusine antibodies and uses thereof (USPTO 12099064)

14. Researchers Submit Patent Application, 'TREATMENT OF CANCER USING COMBINATION THERAPIES COMPRISING GDC-6036 and GDC-0077', for Approval (USPTO 20230321102)

15. Researchers Submit Patent Application, 'NALCN Channel Protein and Modulators Thereof', for Approval (USPTO 20240295565)

16. Patent Issued for Multispecific antigen-binding proteins (USPTO 12053525)

17. Researchers Submit Patent Application, 'Methods Of Treating Lung Cancer With A Pd-1 Axis Binding Antagonist, A Platinum Agent, And A Topoisomerase Ii Inhibitor', for Approval (USPTO 20240261399)

18. 'Methods Of Treating Lung Cancer With A Pd-1 Axis Binding Antagonist, An Antimetabolite, And A Platinum Agent' in Patent Application Approval Process (USPTO 20240252632)

20. Researchers Submit Patent Application, 'Combined Transposon-Mediated Integration And Targeted Integration Of Nucleic Acids Into Host Cells', for Approval (USPTO 20240240156)

21. Patent Issued for Anti-polyubiquitin antibodies and methods of use (USPTO 12037385)

22. Researchers Submit Patent Application, 'Acyclic Oxazepine Compounds Comprising A 6-Aza Moiety And Uses Thereof', for Approval (USPTO 20240228512)

23. Patent Issued for Production of heteromultimeric proteins using mammalian cells (USPTO 12030926)

24. Researchers Submit Patent Application, 'Cysteine Engineered Antibodies and Conjugates', for Approval (USPTO 20240218050)

25. Patent Issued for Synthetic controls for immunohistochemistry (USPTO 12019069)

26. 'Subcutaneous anti-HER2 Antibody Formulations and Uses Thereof' in Patent Application Approval Process (USPTO 20240207400)

27. Patent Issued for PH adjustment to improve thaw recovery of cell banks (USPTO 12016328)

28. Patent Issued for Methods of using anti-CD79b immunoconjugates (USPTO 12016842)

29. Patent Issued for Dual specific antibodies for binding interleukin 4 (IL4) and interleukin 5 (IL5) (USPTO 12006360)

30. Patent Issued for Cell-based assay for detecting anti-CD3 homodimers (USPTO 12007398)

31. Patent Application Titled 'Method for Enriching Extracellular Vesicles From Biological Fluid Samples' Published Online (USPTO 20230204588)

32. Patent Issued for Diagnostic and therapeutic methods for the treatment of breast cancer (USPTO 11676731)

33. Patent Application Titled 'Combination Therapies For Treatment Of Breast Cancer' Published Online (USPTO 20230088701)

34. Patent Issued for Prevention of disulfide bond reduction during recombinant production of polypeptides (USPTO 11999791)

35. Patent Issued for Therapeutic compounds (USPTO 11993599)

36. Patent Issued for Prevention of disulfide bond reduction during recombinant production of polypeptides (USPTO 11987637)

37. Patent Issued for Prevention of disulfide bond reduction during recombinant production of polypeptides (USPTO 11987638)

38. Researchers Submit Patent Application, 'Process For The Preparation Of Benzoxazepin Oxazolidinone Compounds', for Approval (USPTO 20240166595)

39. Patent Issued for Prevention of disulfide bond reduction during recombinant production of polypeptides (USPTO 11976127)

40. Patent Issued for Pharmaceutical compositions comprising Akt protein kinase inhibitors (USPTO 11969426)

41. 'Composition And Methods For Stabilizing Liquid Protein Formulations' in Patent Application Approval Process (USPTO 20240123066)

43. Researchers Submit Patent Application, 'Methods Of Using Anti-Cd79b Immunoconjugates To Treat Diffuse Large B-Cell Lymphoma', for Approval (USPTO 20240115718)

44. Patent Issued for Azaindoles as inhibitors of HPK1 (USPTO 11944606)

45. Researchers Submit Patent Application, 'Anti-Ubiquitination Antibodies And Methods Of Use', for Approval (USPTO 20240109958)

46. 'Bioanalytical Analysis Of Site-Specific Antibody Drug Conjugates' in Patent Application Approval Process (USPTO 20240110909)

47. Patent Application Titled 'Tumor Phenotype Prediction Using Genomic Analyses Indicative Of Digital-Pathology Metrics' Published Online (USPTO 20240105283)

48. Patent Application Titled 'Vial Assembly With Luer Fitting' Published Online (USPTO 20240091100)

49. Researchers Submit Patent Application, 'In Vitro Cell-Based Assay For Predicting Pharmacokinetics And Brain Penetration Of Biologics', for Approval (USPTO 20240085404)

50. Patent Issued for Anti-Jagged2 antibodies and methods of use (USPTO 11926674)

Catalog

Books, media, physical & digital resources